Nel ASA Enters July 15 Earnings With No Analyst Support, a CEO Void, and a 73% Order Collapse

Nel ASA near 52-week lows; no buy ratings, CEO exit, 73% order decline, losses. Shift to smaller projects offers hope but uncertainty persists.

Analysts are broadly shunning Nel ASA ahead of the company’s half-year report due around July 15, with not a single sell-side recommendation urging investors to buy the stock. Berenberg analyst James Carmichael recently trimmed his price target from 2.60 to 2.30 Norwegian kroner while maintaining a neutral stance, reflecting deepening doubts about the Norwegian hydrogen firm’s ability to convert its technology into commercial momentum. The stock closed Friday at €0.21, up 3% on the session, but the longer?term picture remains bleak.

That anaemic price action comes as Nel searches for a new chief executive after Håkon Volldal announced he would leave the company by early 2027 to join packaging group Elopak. The leadership vacuum adds an extra layer of uncertainty at a moment when investors are desperate for clarity on the order pipeline. The board has yet to name a successor, and the absence of a captain has left the stock drifting without a clear catalyst.

The scale of the commercial challenge was laid bare in the first quarter. Order intake crashed 73% year?on?year to just 85 million Norwegian kroner, while the order backlog shrank to 1.1 billion kroner. Against that backdrop, Nel’s cash position of more than 1.4 billion kroner provides a buffer, but the company is burning through it at an operating loss of 100 million kroner per quarter. Management has conceded that the current backlog is insufficient to fill capacity through 2027, placing the entire focus on the pace of new business wins.

One immediate legal cloud has been cleared. Nel reached an out?of?court settlement with Iwatani and Cavendish Hydrogen over a dispute linked to technical issues at California hydrogen refuelling stations, costing the company $7.5 million. That removes a potentially costly distraction in the US, but it does little to address the core problem of sluggish demand for Nel’s equipment.

The company is betting on a strategy shift aimed at smaller, faster?to?market projects. Containerised PEM units, which can be delivered in under twelve months, are now the primary growth vehicle. Early signs of traction appeared in the second quarter: a repeat order worth $7 million in April and a separate contract for around 70 million kroner shortly afterwards. Nel has also slashed headcount by 26% from its peak, trimming personnel costs significantly. An expected EU grant of €11 million for its pressurised alkaline electrolyser technology, due in spring 2026, will bring additional liquidity down the line.

Technically, the stock is hanging by a thread. Over the past 30 days it has lost more than 31% of its value, and annualised volatility stands at 67%. The market capitalisation has shrunk to roughly €380 million. The share price of €0.21 is glued to the 200?day moving average – a make?or?break support level. A break below that line would risk a swift test of the 52?week low of €0.17, while a clear move above the 50?day average of €0.27 would signal a potential recovery. The relative?strength index at 38.8 points to a weak but not yet deeply oversold market.

The half?year report on July 15 is the next hard catalyst. Investors will scrutinise the pace of new orders, the burn rate of the cash pile, and any update on the CEO search for signs that Nel can bridge the gap between its technological promise and commercial reality. Until then, the stock remains at the mercy of the chart.